Skip to content
 

Three Quick Facts: Computacenter, MyHealthChecked and Go Ahead Group

*

Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.

#1. Computacenter stock shortage sees customers accelerate orders

Computacenter [LON:CCC] has published a pre-close trading update this morning, based on preliminary results for the 12 months to 31st December. Total revenue, including acquisitions, was up by 23% and the company notes the momentum seen in Q4 offers strong encouragement over the outlook for the new year. Product supply constraints have customers ordering earlier, whilst there’s also significant underlying strength in the market. Final resulst are expected around mid-March.

#2.  Another revenue upgrade from COVID testing company MyHealthChecked

AIM Listed MyHealthChecked [LON:MHC] has been in focus given the role it has been playing in terms of lateral flow testing for COVID. The company issued a trading statement this morning noting that full year results are now set to exceed already upgraded expectations. Revenues are now eyed as coming in around £16.3m, up from £49,500 a year ago with an EBITDA profit of at least £2.5m. The board expects cash balances of around £6.3m and notes that the company has a strong pipeline of new products in the at-home wellness category which is plans to launch in the coming months. Could a change in how we collectively look at health be a lasting legacy of the pandemic?

#3. Go Ahead Group delayed results now expected by end of February

There’s a short update from public transport operator Go Ahead Group [LON:GOG], whose securities are currently suspended. That’s owing to delays in preparing audited results for the year to 3rd July, after accounting irregularities were revealed in relation to taxpayer funding for rail operations that should have been repaid. Expectations are now that these results will be ready for publication by the end of February.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
Pepperstone
WisdomTree
CME Group
Back To Top